ECP 2022 Final Programme

Poster Sessions a Monday 96 Monday, 5 Sept PS-10 PS-MD-01 006 Anastomosing haemangioma with unusual location and mimicking malignancy: a case series and literature review Ezgi Dicle Serbes, Turkey E. Gedik, S. Yuksel, G. Kaygusuz 007 Three cases of Kaposi sarcoma as initial manifestation of HIV infection and AIDS Jovan Jevtic, Serbia L. Simic, R. Janković, S. Rajkovic, G. Djuricic, J. Sopta 008 Pediatric chordomas: report of five cases with emphasis on poorly differentiated subtype and SMARCB1/INI1 deficiency Zeynep Betül Erdem, Turkey A. Onenerk Men, S. Tuter, S. Ocak, N. Comunoglu 009 Does MYC-amplification help distinguish- ing primary from radiation-induced angiosarcomas? Barbara Raposo Pulido, Spain J. Rodríguez Barbero, F. Camacho Castañeda, A. Ballén Barragán, M. Granados Almillo, J. Morillo Morillo, R. Granados Carreño 010 Usufullnes of novel SS18-SSX and SSX c-terminus antibodies for identification of specific fusion oncoprotein in sarcomas Theresa Marie Godschachner, Austria J. Igrec, S. Scheipl, A. Leithner, B. Liegl- Atzwanger, I. Brcic 011 Chordoma: significance and correlation of the localisation, vascular density and Ki67 for the occurrence of chordoma recur- rence Ljubica Simic, Serbia J. Jevtic, M. Radojevic, D. Ribic, S. Rajkovic, G. Djuricic, D. Ristic, J. Sopta PS-MD-01 Poster Session Poster Session MD Symposium Chair: Carina Heydt, Germany 001 EIF1AX mutations in thyroid nodules: analysis of a series of 1095 consecutive cases Federico Chiarucci, Italy D. de Biase, A. De Leo, A. Corradini, M. Sirolli, G. Simoncini, A. Orsatti, L. Di Sciascio, T. Maloberti, S. Coluccelli, G. Tallini 003 First steps in molecular classification in endometrial carcinoma: experience in a low income country Hayet Douik, Tunisia R. Doghri, G. Sahraoui, M. Ghalleb, M. Rajoua, O. Azaiez, M. Hechiche, M. Kharrat, K. Mrad, L. Charfi 004 Genomic landscape of 63 samples of 29 Hungarian breast cancer patients Anna Mária Tokés, Hungary O. Pipek, D. Alpár, O. Rusz, Z. Udvarnoki, I. Csabai, C. Bödör, L. Madaras, Z. Kahán, B. Kővári, J. Kulka 005 Learnings from two years of external quality assessment (EQA) for BRCA1/ BRCA2 testing in metastatic castration-re- sistant prostate cancer (mCRPC) Victoria Williams, United Kingdom J. Fairley, M. Woodcock, M. Cheetham, N. Wolstenholme, Z. Deans, S. Patton